Gottfried und Julia Bangerter-Rhyner Foundation, Switzerland Report issue

Foundation

Organization Overview

First Clinical Trial
2015
NCT02510911
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Gottfried und Julia Bangerter-Rhyner-Stiftung